Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Determine which no fee travel card is better suited for you. Make the right choice for your travel goals and preferences.
22,600 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A cliff-like Medicare IRMAA rule makes a tiny annual income step cost retirees hundreds more each month. This report ...
Fans and investors alike crave clarity on Funko's 2025 earnings. This guide breaks down revenue streams, margin dynam...
Darden Restaurants reports quarterly results as higher fuel costs and a meatpacking strike ripple through its supply ...
Bitcoin hovers near $74,000 as market eyes Powell and the Fed. An analyst warns of a repeat sell-the-news pattern, ev...
DeFi founders argue that tokenized assets are the next growth lever, linking real-world value to on-chain liquidity. ...
A geopolitical clash has spilled into cyberspace, unleashing AI-augmented attacks on corporate networks. Fortune 500 ...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Markets tremble as Iran tensions flare and policy choices loom. This report explains how trump seems have himself cou...
Traders are flocking to Hyperliquid for round-the-clock oil trades on decentralized platforms. A JPMorgan note signal...
A new AI compute niche is gaining attention as investors search for growth beyond mega-cap tech. This article outline...
The World Gold Council unveiled a blockchain-backed trust layer to link physical gold vaults with digital rails, sign...